Gotowe bibliografie tematyczne / Distinct entity / Artykuły w czasopismach

Artykuły w czasopismach na temat „Distinct entity”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Distinct entity.
Autor: Grafiati
Data publikacji: 13 kwietnia 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Distinct entity”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Husein El Ahmed, Husein, i Carmen Dulanto-Campos. "A distinct entity". American Journal of Obstetrics and Gynecology 208, nr 1 (styczeń 2013): 89.e1–89.e2. http://dx.doi.org/10.1016/j.ajog.2012.10.864.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Gleich, Tobias, Elena Chiticariu, Marcel Huber i Daniel Hohl. "Keratoacanthoma: a distinct entity?" Experimental Dermatology 25, nr 2 (4.12.2015): 85–91. http://dx.doi.org/10.1111/exd.12880.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Grof, Paul. "Melancholia: A Distinct Entity?" Canadian Journal of Psychiatry 58, nr 4 (kwiecień 2013): 181–82. http://dx.doi.org/10.1177/070674371305800401.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

H. Khaparde, Sadhana, Sanjay D. Deshmukh, Baba B. Shinde, Prajacta Rane i Shaleen Lamba. "Sialadenoma Papilliferum of Buccal Mucosa : A Rare and Distinct Entity". Indian Journal of Pathology: Research and Practice 5, nr 2 (2016): 219–21. http://dx.doi.org/10.21088/ijprp.2278.148x.5216.28.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Agarwal, Amar, Priya Narang i DhivyaAshok Kumar. "Predescemetocele: A distinct clinical entity". Indian Journal of Ophthalmology 65, nr 11 (2017): 1224. http://dx.doi.org/10.4103/ijo.ijo_492_17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Bomback, Andrew S., i Glen S. Markowitz. "Lupus Podocytopathy: A Distinct Entity". Clinical Journal of the American Society of Nephrology 11, nr 4 (16.03.2016): 547–48. http://dx.doi.org/10.2215/cjn.01880216.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Joshi, Rajiv, i Yatin Jadhav. "Penoscrotal porokeratosis: A distinct entity". Indian Dermatology Online Journal 6, nr 5 (2015): 339. http://dx.doi.org/10.4103/2229-5178.164487.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Levine, Jimmy, Michael H. Schmidt, Morton I. Burrell i Michael S. Hopkins. "Acute Jejunoileitis. A Distinct Entity?" Journal of Clinical Gastroenterology 14, nr 1 (styczeń 1992): 47–51. http://dx.doi.org/10.1097/00004836-199201000-00012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Walters, Glenn D. "Dementia: Continuum or distinct entity?" Psychology and Aging 25, nr 3 (2010): 534–44. http://dx.doi.org/10.1037/a0018167.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

McMillan, Marcia J., i R. O. Pihl. "Premenstrual depression: A distinct entity." Journal of Abnormal Psychology 96, nr 2 (1987): 149–54. http://dx.doi.org/10.1037/0021-843x.96.2.149.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Dixon, M. F., H. J. O'Connor, A. T. Axon, R. F. King i D. Johnston. "Reflux gastritis: distinct histopathological entity?" Journal of Clinical Pathology 39, nr 5 (1.05.1986): 524–30. http://dx.doi.org/10.1136/jcp.39.5.524.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Pranteda, Bottoni, De Simone, Calvieri i Grieco. "Bullous keloid: a distinct entity?" British Journal of Dermatology 141, nr 2 (sierpień 1999): 375–77. http://dx.doi.org/10.1046/j.1365-2133.1999.03013.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Yazıcı, Olcay. "Unipolar mania: A distinct entity?" Journal of Affective Disorders 152-154 (styczeń 2014): 52–56. http://dx.doi.org/10.1016/j.jad.2013.10.005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Amarapurkar, Anjali D., Deepak Amarapurkar, Mehul Choksi, Nirav Bhatt i Pooja Amarapurkar. "Portal hypertensive polyps: distinct entity". Indian Journal of Gastroenterology 32, nr 3 (20.03.2013): 195–99. http://dx.doi.org/10.1007/s12664-013-0324-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Ammann, Roland A., Jack Plaschkes i Kurt Leibundgut. "Congenital hepatoblastoma: A distinct entity?" Medical and Pediatric Oncology 32, nr 6 (czerwiec 1999): 466–68. http://dx.doi.org/10.1002/(sici)1096-911x(199906)32:6<466::aid-mpo20>3.0.co;2-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Korelitz, Burton I., i Jeffrey Aronoff. "Crohnʼs proctitis: A distinct entity". Inflammatory Bowel Diseases 16, nr 5 (maj 2010): 721–22. http://dx.doi.org/10.1002/ibd.21089.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Hennekam, R. C. M. "LADD syndrome: a distinct entity?" European Journal of Pediatrics 146, nr 1 (styczeń 1987): 94–95. http://dx.doi.org/10.1007/bf00647303.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

LEVINSON, JOSEPH E. "Eosinophilic Fasciitis: A Distinct Entity?" Archives of Pediatrics & Adolescent Medicine 139, nr 1 (1.01.1985): 8. http://dx.doi.org/10.1001/archpedi.1985.02140030010001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Garg, RavindraKumar, GyanPrakash Singh, Rajiv Garg, Neeraj Kumar i Anit Parihar. "Severe COVID-19: A distinct entity". Journal of Family Medicine and Primary Care 10, nr 1 (2021): 84. http://dx.doi.org/10.4103/jfmpc.jfmpc_1600_20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Pawar, Vipul Mohan. "Verruciform Xanthoma-Histopathologically: A Distinct Entity". Journal of Contemporary Dentistry 4, nr 3 (2014): 181–84. http://dx.doi.org/10.5005/jp-journals-10031-1093.

Pełny tekst źródła
Streszczenie:
ABSTRACT Verruciform xanthoma (VX) is an uncommon benign mucocutaneous lesion of unknown etiology. It is essential to diagnose this lesion as a varied entity of utmost importance as clinically their appearance could range from a simple leukoplakia or papilloma to as grave as squamous cell carcinoma SCC. Although this lesion is of multifactorial pathogenesis, a viral etiology like human papilloma virus (HPV) has been suggested in some cases. This rare, harmless lesion usually presents as a sessile or pedunculated, pale yellowish-to-red, papillary, granular or verrucous mucosal growth. Histopathologically, VX is characterized by the presence of parakeratinzed epithelium showing papillary or verrucous growth with thin rete ridges and connective tissue papillae extending up to the surface. The papillae characteristically consist of foam cells, also called xanthoma cells. We report two cases of VX of varied clinical appearance but very similar and characteristic histopathological presentation to be diagnosed as VX. The clinical diagnosis, though may be challenging; the histopathological features are diagnostic and well-defined. It is also noteworthy that in an improper biopsy, xanthoma cells may be scanty and their presence can be missed, especially if one is unfamiliar with the existence of this lesion. How to cite this article Pawar VM, Patel S, Pathak J, Swain N. Verruciform Xanthoma-Histopathologically: A Distinct Entity. J Contemp Dent 2014;4(3):181-184.
Style APA, Harvard, Vancouver, ISO itp.
21

Ray, Katrina. "Eosinophilic colitis — a distinct clinical entity?" Nature Reviews Gastroenterology & Hepatology 19, nr 3 (1.02.2022): 148. http://dx.doi.org/10.1038/s41575-022-00583-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Kansal, NaveenKumar, C. Divyalakshmi i Aditi Dhanta. "Lichenoid psoriasis: A distinct morphological entity". Clinical Dermatology Review 4, nr 1 (2020): 67. http://dx.doi.org/10.4103/cdr.cdr_15_19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Morris, Gabrielle F., Katrina Murphy, Lucy B. Rorke i Hector E. James. "Spinal hamartomas: a distinct clinical entity". Journal of Neurosurgery 88, nr 6 (czerwiec 1998): 954–61. http://dx.doi.org/10.3171/jns.1998.88.6.0954.

Pełny tekst źródła
Streszczenie:
Object. Congenital spinal hamartomas are defined as tumors of well-differentiated mature elements situated in an abnormal location. In this report, the authors document the clinical and pathological features of spinal hamartomas in 10 patients. Methods. Ten patients presented with midline dorsal malformations at birth, initially diagnosed as teratomas or myelomeningoceles. The locations of the masses were variable: two were located in the thoracic region, four at the thoracolumbar junction, two in the lumbar region, one at the lumbosacral junction, and one in the sacral region. The results of the neurological examination were normal in nine patients. All but one mass had intact skin and seven had palpable bone components. Neuroimaging studies revealed widening of the spinal canal, heterotopic bone located dorsally in some patients, and varying degrees of involvement of the intraspinal contents. During surgery, six patients were found to have involvement of the spinal cord or cauda equina. The pathological characteristics of the masses included three or more of the following: bone, cartilage, synovial membrane, urinary tract tissue, cyst wall, yellow or brown fat, and nerves. The well-differentiated cellular elements, which formed mature structures, along with the absence of primitive cellular components and neoplastic characteristics are more consistent with a diagnosis of hamartoma than teratoma. Conclusions. In this series, the authors describe a lesion that is overt on physical examination, yet can have occult spinal canal involvement. Complete neurosurgical evaluation is essential to provide appropriate treatment and prognosis.
Style APA, Harvard, Vancouver, ISO itp.
24

Wasserfallen, Jean-Blaise, Marie-Denise Schaller, Francois Feihl i Claude H. Perret. "Sudden Asphyxic Asthma: A Distinct Entity?" American Review of Respiratory Disease 142, nr 1 (lipiec 1990): 108–11. http://dx.doi.org/10.1164/ajrccm/142.1.108.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Strong, Russell W. "DIEULAFOY'S DISEASE-A DISTINCT CLINICAL ENTITY". Australian and New Zealand Journal of Surgery 54, nr 4 (21.01.2008): 337–39. http://dx.doi.org/10.1111/j.1445-2197.1984.tb05329.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Sabatelli, M., F. Madia, L. De Armas i P. Tonali. "PURE MOTOR CIDP. A DISTINCT ENTITY?" Journal of the Peripheral Nervous System 5, nr 1 (marzec 2000): 49. http://dx.doi.org/10.1046/j.1529-8027.2000.00513-52.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

FLETCHER, C. D. M., S. E. DAVIES i P. H. MCKEE. "Cellular schwannoma: a distinct pseudosarcomatous entity". Histopathology 11, nr 1 (3.04.2007): 21–35. http://dx.doi.org/10.1111/j.1365-2559.1987.tb02606.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Gertz, Morie A., Francis K. Buadi, Suzanne R. Hayman, David Dingli, Angela Dispenzieri, Philip R. Greipp, Shaji K. Kumar i in. "Immunoglobulin D amyloidosis: a distinct entity". Blood 119, nr 1 (5.01.2012): 44–48. http://dx.doi.org/10.1182/blood-2011-06-358895.

Pełny tekst źródła
Streszczenie:
Abstract IgD monoclonal gammopathies are uncommon. They are seen rarely as a monoclonal gammopathy of undetermined significance and are present in 1%-2% of patients with multiple myeloma. In light-chain amyloidosis, IgD monoclonal proteins are found in ap-proximately 1% of patients. When an IgD monoclonal protein is found, amyloidosis is often omitted from the differential diagnosis. In the present study, we reviewed the natural history of IgD-associated amyloidosis among 53 patients seen over 41 years. The distribution of clinical syndromes suggests that these patients have a lower frequency of renal and cardiac involvement. The overall survival of these patients does not appear to be different from that of patients who have light-chain amyloidosis associated with another monoclonal protein.
Style APA, Harvard, Vancouver, ISO itp.
29

van der Meijden, Willem I., i Patricia C. Ewing. "Papular Colpitis: A Distinct Clinical Entity?" Journal of Lower Genital Tract Disease 15, nr 1 (styczeń 2011): 60–65. http://dx.doi.org/10.1097/lgt.0b013e3181dc2f6a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Amarapurakar, Deepak, Anjali D. Amarapurkar, Nirav Bhatt, Mehul J. Choksi i Pooja Amarapurkar. "Su1959 Portal Hypertensive Polyps: Distinct Entity". Gastroenterology 142, nr 5 (maj 2012): S—546. http://dx.doi.org/10.1016/s0016-5085(12)62098-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Oliver, G. Fergus, i R. K. Winkelmann. "Unilesional mycosis fungoides: A distinct entity". Journal of the American Academy of Dermatology 20, nr 1 (styczeń 1989): 63–70. http://dx.doi.org/10.1016/s0190-9622(89)70008-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Smith, Dr Molly, Dr Craig Fowler, Dr Indraneel Bhattacharyya, Dr Rekha Reddy i Dr Douglas Damm. "AMELOBLASTIC fiBRO-ODONTOMA: A DISTINCT ENTITY". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 128, nr 1 (lipiec 2019): e89. http://dx.doi.org/10.1016/j.oooo.2019.02.227.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Dhondt, E., L. Oudenhoven, S. Khan, H. M. Kroon, P. C. Hogendoorn(•), A. Nieborg, J. L. Bloem i A. De Schepper. "Nora’s lesion, a distinct radiological entity?" Skeletal Radiology 35, nr 7 (7.04.2006): 497–502. http://dx.doi.org/10.1007/s00256-005-0041-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Hyser, Craig L., John T. Kissel, John R. Warmolts i Jerry R. Mendell. "Scapuloperoneal neuropathy: A distinct clinicopathologic entity". Journal of the Neurological Sciences 87, nr 1 (październik 1988): 91–102. http://dx.doi.org/10.1016/0022-510x(88)90057-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Mori, Makoto, Robert W. Elder i Wendy M. Book. "Adult Fontan failure — Distinct disease entity". International Journal of Cardiology 177, nr 2 (grudzień 2014): 650. http://dx.doi.org/10.1016/j.ijcard.2014.09.177.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Krutchkoff, David J., i Ellen Eisenberg. "Lichenoid dysplasia: A distinct histopathologic entity". Oral Surgery, Oral Medicine, Oral Pathology 60, nr 3 (wrzesień 1985): 308–15. http://dx.doi.org/10.1016/0030-4220(85)90315-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Bitton, Rachelle N., i Craig Wexler. "Free triiodothyronine toxicosis: A distinct entity". American Journal of Medicine 88, nr 5 (maj 1990): 531–33. http://dx.doi.org/10.1016/0002-9343(90)90435-g.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Sakata, Shigeki, i Toru Ogawa. "Free T3 toxicosis: A distinct entity?" American Journal of Medicine 91, nr 1 (lipiec 1991): 100. http://dx.doi.org/10.1016/0002-9343(91)90083-a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Behranwala, K. A., i J. M. Thomas. "‘Aggressive’ angiomyxoma: a distinct clinical entity". European Journal of Surgical Oncology (EJSO) 29, nr 7 (wrzesień 2003): 559–63. http://dx.doi.org/10.1016/s0748-7983(03)00104-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Van Borsel, John, Sandie Van Der Made i Patrick Santens. "Thalamic stuttering: A distinct clinical entity?" Brain and Language 85, nr 2 (maj 2003): 185–89. http://dx.doi.org/10.1016/s0093-934x(03)00061-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Weatherald, Jason, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert i David Montani. "Pulmonary capillary haemangiomatosis: a distinct entity?" European Respiratory Review 29, nr 156 (27.05.2020): 190168. http://dx.doi.org/10.1183/16000617.0168-2019.

Pełny tekst źródła
Streszczenie:
Pulmonary capillary haemangiomatosis (PCH) is a rare and incompletely understood histopathological finding characterised by abnormal capillary proliferation within the alveolar interstitium, which has long been noted to share many overlapping features with pulmonary veno-occlusive disease (PVOD). But are PCH and PVOD distinct entities that occur in isolation, or are they closely intertwined manifestations along a spectrum of the same disease? The classic clinical features of both PCH and PVOD include signs and symptoms related to pulmonary hypertension, hypoxaemia, markedly impaired diffusion capacity of the lung and abnormal chest imaging with ground glass opacities, septal lines and lymphadenopathy. In recent years, increasing evidence suggests that the clinical presentation, histopathological features, genetic substrate and pathobiological mechanisms of PCH and PVOD are overlapping and usually indistinguishable. The discovery of biallelic mutations in the eukaryotic translation initiation factor 2 α kinase 4 (EIF2AK4) gene in heritable PCH and PVOD greatly advanced our understanding of the overlapping nature of these conditions. Furthermore, recognition of PCH and PVOD-like changes in other pulmonary vascular diseases and in conditions that cause chronic pulmonary venous hyper-perfusion or hypertension suggests that PCH/PVOD may develop as a reactive process to various insults or injuries to the pulmonary vasculature, rather than being primary angiogenic disorders.
Style APA, Harvard, Vancouver, ISO itp.
42

Steensma, David P., Curtis A. Hanson, Louis Letendre i Ayalew Tefferi. "Myelodysplasia with fibrosis: a distinct entity?" Leukemia Research 25, nr 10 (październik 2001): 829–38. http://dx.doi.org/10.1016/s0145-2126(01)00055-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Durrani, Khayyam, i C. Stephen Foster. "Psoriatic uveitis: A distinct clinical entity?" American Journal of Ophthalmology 139, nr 1 (styczeń 2005): 106–11. http://dx.doi.org/10.1016/j.ajo.2004.08.053.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Mackworth-Young, Charles. "Primary antiphospholipid syndrome: A distinct entity?" Autoimmunity Reviews 5, nr 1 (styczeń 2006): 70–75. http://dx.doi.org/10.1016/j.autrev.2005.08.001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Cohen, Pierre Alain, G. Kalifa, Veronica Donoghue, Catherine Adamsbaum, Faddy Haddad i Jean Dubousset. "Ischio-vertebral dysplasia: a distinct entity". Pediatric Radiology 29, nr 2 (29.01.1999): 131–34. http://dx.doi.org/10.1007/s002470050556.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Shin, Jung-Ha, Tae-Eun Kim, Kyo-Young Lee, Sang-In Shim i Yeong-Jin Choi. "C1q Nephropathy: A Distinct Pathologic Entity". Korean Journal of Pathology 43, nr 4 (2009): 335. http://dx.doi.org/10.4132/koreanjpathol.2009.43.4.335.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Kumar, Bhushan, i Davinder Parsad. "Is ‘Nodular Tuberculid’ A Distinct Entity?" Pediatric Dermatology 18, nr 2 (marzec 2001): 165–66. http://dx.doi.org/10.1046/j.1525-1470.2001.01894-3.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Kokal, William A., L. Robert Hill, David Porudominsky, J. David Beatty, M. Margaret Kemeny, Daniel U. Riihimaki i Ose J. Terz. "Inflammatory breast carcinoma: A distinct entity?" Journal of Surgical Oncology 30, nr 3 (19.07.2006): 152–55. http://dx.doi.org/10.1002/jso.2930300306.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Roach, E. S. "Is Neuromyelitis Optica a Distinct Entity?" Archives of Neurology 64, nr 6 (1.06.2007): 906. http://dx.doi.org/10.1001/archneur.64.6.906.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Gulia, Joyti, Shambu Aryal, Haval Saadlla i Andrew F. Shorr. "Healthcare-associated candidemia-A distinct entity?" Journal of Hospital Medicine 5, nr 5 (9.06.2010): 298–301. http://dx.doi.org/10.1002/jhm.652.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Distinct entity” dla innych typów źródeł:
Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii